Facts & Stats

Houston Methodist is re-engineering the future of medicine with translational research and education that has demonstrable impact on clinical care. The Academic Institute’s $28.8 million Translational Research Initiative product development fund supports the specialized talent and technology that enables the full cycle of development to efficiently and effectively deliver innovations to the clinic. Integrated into U.S. News & World Report’s No. 1 hospital in Texas and named one of America’s “Best Hospitals,” the Academic Institute aligns our research and education initiatives in service to the clinical mission, providing solutions that answer the call for new technologies and skills our clinicians need for patient care. 


Houston Methodist

  • 8 hospitals
  • 2.23 million patient encounters
  • 2.09 million outpatient visits
  • 141,811 admissions
  • 32,058 employees
  • 5,069 affiliated physicians
  • 815 faculty
  • $299 million research & education investment
  • 2,340 credentialed researchers
  • 67,000 learners

Research Funding

  • $202 million in annual research expenditures
  • $71 million in annual education expenditures
  • $90 million in total extramural funding
  • $41 million in National Institutes of Health funding
  • $31 million Translational Research Initiative product development fund

Academic Affiliations & People

  • 815 faculty
  • 2,340 credentialed researchers
  • Affiliated with Weill Cornell Medical School


  • 232 licensable technologies
  • 22 products in the pipeline
  • 1,430 clinical protocols
  • 530 active clinical trials
  • 212 investigator initiated trials
  • 2,000 peer-reviewed publications
  • 136 collaborating countries
  • 6,690 global collaborations
  • 19 Interdisciplinary Departments: Anesthesiology & Critical Care; Cardiology; Cardiovascular Sciences; Cardiovascular Surgery; Medicine; Nanomedicine; Stanley H. Appel Department of Neurology; Neurosurgery; Obstetrics & Gynecology; Ophthalmology; Oral & Maxillofacial Surgery; Orthopedic Surgery; Otolaryngoloy; Pathology & Genomic Medicine; Psychiatry and Behavioral Health; Radiation Oncology; Radiology; Surgery; Urology
  • 19 Interdisciplinary Centers: Cellular Therapeutics; Bioenergetics; Cardiovascular Regeneration; Health Data Science and Analytics; Human Performance; Critical Care; Health and Nature; Robotics, Imaging and Navigation; Immunobiology and Transplant Science; Infectious Diseases; Brain and Pituitary Treatment; Musculoskeletal Regeneration; Alzheimer’s Disease; Neuroregeneration; Neural Systems Restoration; Rapid Device Translation; RNA Therapeutics; Liver Disease and Transplantation


  • EnMed: Texas A&M University School of Engineering Medicine at Houston Methodist combined MD and master's in engineering program
  • Master's in Clinical Translational Management with University of St. Thomas
  • 71 GME programs; 388 residents & fellows
  • 67,000 annual learners
  • 1,230 trainees in residence for medicine, research, nursing, pharmacy, and allied health
  • Houston Methodist Institute for Technology, Innovation & Education (MITIEā„ )


  • Ann Kimball & John W. Johnson Center for Cellular Therapeutics to translate laboratory discoveries into cutting-edge cellular therapies for patient care
  • Center for RNA Therapeutics provides access to state-of-the-art for RNA manufacturing and technology
  • Imaging innovation hub: A Siemens and Houston Methodist led consortium with Rice University, Texas A&M, UT Health Science Center at Houston, UT Medical Branch at Galveston, University of Houston, and Baylor College of Medicine
  • 7 Tesla MRI and MAGNETOM Terra, allowing for unprecedented visualization of anatomical details, physiology and biological function
  • Cyclotron and 9 ventilated hot cells (chemistry labs in lead boxes) to produce clinical grade and rare custom radiopharmaceuticals for advanced diagnostic and therapeutic imaging
  • Inveon dedicated PET system, Inveon multimodality SPECT/CT system, Caliper IVIS-200 system, and Maestro in vivo fluorescence imaging system
  • Good Laboratory Practice (GLP) facilities perform risk, safety and efficacy assessment studies in compliance with FDA guidelines in preclinical models
  • Current Good Manufacturing Practices (cGMP) facilities to produce pharmaceuticals, vaccines and nanoparticles for testing and research
  • Cockrell Center for Advanced Therapeutics Clinical Research Phase I Unit to support clinical investigators and sponsors with early phase and proof-of-concept clinical trials
  • 21 core facilities for access to pioneering technology and data analysis, including: advanced cellular and tissue microscopy; biorepository; biostatistics and bioinformatics; clinical research services; comparative medicine; digital solutions; electron microscopy; event services; flow cytometry; high performance computing; immunomonitoring; intravital microscopy; machine shop; magnetic stimulation devices; nanoengineering; preclinical catheterization lab; research pathology; RNAcore; translational imaging; translational production & quality

Consortia & Collaborative Centers

  • Gulf Coast Consortium
  • Center for Translational Neural Systems Restoration, in partnership with Rice University
  • Center for Human Performance, in collaboration with Rice University
  • Center for Cell and Gene Therapy, in partnership with Baylor College of Medicine and Texas Children’s Hospital 
  • Center for Health and Nature, in partnership with Texas A&M University and Texan by Nature
  • Center for Rapid Device Translation, in partnership with J&J Innovation Labs
  • Siemens Imaging Consortium, based at Houston Methodist with six local universities and medical centers